Found: 3
Select item for more details and to access through your institution.
Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as “Isoglycemic” Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 4, p. 945, doi. 10.1210/jc.2010-2178
- By:
- Publication type:
- Article
Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9-39] as a GLP-1 Receptor Antagonist.
- Published in:
- 2016
- By:
- Publication type:
- journal article
GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 Diabetes.
- Published in:
- Diabetes, 2011, v. 60, n. 4, p. 1270, doi. 10.2337/db10-1332
- By:
- Publication type:
- Article